NEW YORK, May 10, 2018 /PRNewswire/ -- Rowley Law PLLC
is investigating potential claims against ARMO BioSciences, Inc.
(NASDAQ: ARMO) and its board of directors for breach of fiduciary
duty concerning the proposed acquisition of the company by Eli
Lilly and Company. Stockholders
will receive $50.00 for each share of
ARMO BioSciences stock that they hold. The transaction is valued at
approximately $1.6 billion and is
expected to close by the end of the second quarter of 2018.
If you are a stockholder of ARMO BioSciences, Inc. and are
interested in obtaining additional information regarding this
investigation, please visit us at:
http://www.rowleylawpllc.com/investigation/armo. You may
also contact Shane Rowley, Esq. at
Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at
info@rowleylawpllc.com, or by telephone at 914-400-1920 or
844-400-4643 (toll-free).
Rowley Law PLLC represents shareholders nationwide in class
actions and derivative lawsuits in complex corporate litigation.
For more information about the firm and its attorneys, please visit
http://www.rowleylawpllc.com.
Attorney Advertising. Prior results do not guarantee a similar
outcome.
View original
content:http://www.prnewswire.com/news-releases/alert-rowley-law-pllc-is-investigating-proposed-acquisition-of-armo-biosciences-inc-300646481.html
SOURCE Rowley Law PLLC